APO RESEARCH · REPORT
Crude Heparin
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916.
Product & engineering
Understand the product.
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916.
Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines.
Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Selected research
Industry Research
Crude Heparin Industry Research Report 2026
Market perspective
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916.
Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines.
Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Read the full market overview
The Top 5 manufacturers, Bioiberica, Shenzhen Hepalink, Nanjing King-friend, Sanofi and Fengrun Biological, held 56.28% of the market, in terms of revenue in 2019.
Report Scope
This report quantifies the global Crude Heparin market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Crude Heparin Market by Company
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
Crude Heparin Segment by Type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Crude Heparin Segment by Application
Unfractionated Heparin (UFH)
Low-Molecular-Weight Heparin (LMWH)
Crude Heparin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crude Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Crude Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crude Heparin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Crude Heparin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Crude Heparin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Crude Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
Applications
- Unfractionated Heparin (UFH)
- Low-Molecular-Weight Heparin (LMWH)
Companies covered
- Bioiberica
- Shenzhen Hepalink
- Sanofi
- Nanjing King-friend
- Fengrun Biological Technology
- Aspen Oss
- Hebei Changshan Biochemical
- Changzhou Qianhong
- Hepac (Darling Ingredients)
- Huaian MDC Pharmaceutical
- Yantai Dongcheng Biochemicals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Crude Heparin Market Size (2021-2032)
- 2.2.2 Global Crude Heparin Sales (2021-2032)
- 2.2.3 Global Crude Heparin Market Average Price (2021-2032)
- 2.3 Crude Heparin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pig Intestine Mucosa Heparin
- 2.3.3 Bovine Heparin and Others
- 2.4 Crude Heparin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Unfractionated Heparin (UFH)
- 2.4.3 Low-Molecular-Weight Heparin (LMWH)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Crude Heparin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Crude Heparin Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Crude Heparin Revenue of Manufacturers (2021-2026)
- 3.4 Global Crude Heparin Average Price by Manufacturers (2021-2026)
- 3.5 Global Crude Heparin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Crude Heparin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Crude Heparin, Product Type & Application
- 3.8 Global Manufacturers of Crude Heparin, Established Date
- 3.9 Global Crude Heparin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bioiberica
- 4.1.1 Bioiberica Company Information
- 4.1.2 Bioiberica Business Overview
- 4.1.3 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bioiberica Crude Heparin Product Portfolio
- 4.1.5 Bioiberica Recent Developments
- 4.2 Shenzhen Hepalink
- 4.2.1 Shenzhen Hepalink Company Information
- 4.2.2 Shenzhen Hepalink Business Overview
- 4.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shenzhen Hepalink Crude Heparin Product Portfolio
- 4.2.5 Shenzhen Hepalink Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Crude Heparin Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Nanjing King-friend
- 4.4.1 Nanjing King-friend Company Information
- 4.4.2 Nanjing King-friend Business Overview
- 4.4.3 Nanjing King-friend Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Nanjing King-friend Crude Heparin Product Portfolio
- 4.4.5 Nanjing King-friend Recent Developments
- 4.5 Fengrun Biological Technology
- 4.5.1 Fengrun Biological Technology Company Information
- 4.5.2 Fengrun Biological Technology Business Overview
- 4.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fengrun Biological Technology Crude Heparin Product Portfolio
- 4.5.5 Fengrun Biological Technology Recent Developments
- 4.6 Aspen Oss
- 4.6.1 Aspen Oss Company Information
- 4.6.2 Aspen Oss Business Overview
- 4.6.3 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Aspen Oss Crude Heparin Product Portfolio
- 4.6.5 Aspen Oss Recent Developments
- 4.7 Hebei Changshan Biochemical
- 4.7.1 Hebei Changshan Biochemical Company Information
- 4.7.2 Hebei Changshan Biochemical Business Overview
- 4.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hebei Changshan Biochemical Crude Heparin Product Portfolio
- 4.7.5 Hebei Changshan Biochemical Recent Developments
- 4.8 Changzhou Qianhong
- 4.8.1 Changzhou Qianhong Company Information
- 4.8.2 Changzhou Qianhong Business Overview
- 4.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Changzhou Qianhong Crude Heparin Product Portfolio
- 4.8.5 Changzhou Qianhong Recent Developments
- 4.9 Hepac (Darling Ingredients)
- 4.9.1 Hepac (Darling Ingredients) Company Information
- 4.9.2 Hepac (Darling Ingredients) Business Overview
- 4.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hepac (Darling Ingredients) Crude Heparin Product Portfolio
- 4.9.5 Hepac (Darling Ingredients) Recent Developments
- 4.10 Huaian MDC Pharmaceutical
- 4.10.1 Huaian MDC Pharmaceutical Company Information
- 4.10.2 Huaian MDC Pharmaceutical Business Overview
- 4.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Portfolio
- 4.10.5 Huaian MDC Pharmaceutical Recent Developments
- 4.11 Yantai Dongcheng Biochemicals
- 4.11.1 Yantai Dongcheng Biochemicals Company Information
- 4.11.2 Yantai Dongcheng Biochemicals Business Overview
- 4.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Yantai Dongcheng Biochemicals Crude Heparin Product Portfolio
- 4.11.5 Yantai Dongcheng Biochemicals Recent Developments
5 Global Crude Heparin Market Scenario by Region
- 5.1 Global Crude Heparin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Crude Heparin Sales by Region: 2021-2032
- 5.2.1 Global Crude Heparin Sales by Region: 2021-2026
- 5.2.2 Global Crude Heparin Sales by Region: 2027-2032
- 5.3 Global Crude Heparin Revenue by Region: 2021-2032
- 5.3.1 Global Crude Heparin Revenue by Region: 2021-2026
- 5.3.2 Global Crude Heparin Revenue by Region: 2027-2032
- 5.4 North America Crude Heparin Market Facts & Figures by Country
- 5.4.1 North America Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Crude Heparin Sales by Country (2021-2032)
- 5.4.3 North America Crude Heparin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Crude Heparin Market Facts & Figures by Country
- 5.5.1 Europe Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Crude Heparin Sales by Country (2021-2032)
- 5.5.3 Europe Crude Heparin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Crude Heparin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Crude Heparin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Crude Heparin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Crude Heparin Market Facts & Figures by Country
- 5.7.1 South America Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Crude Heparin Sales by Country (2021-2032)
- 5.7.3 South America Crude Heparin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Crude Heparin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Crude Heparin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Crude Heparin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Crude Heparin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Crude Heparin Sales by Type (2021-2032)
- 6.1.1 Global Crude Heparin Sales by Type (2021-2032) & (t)
- 6.1.2 Global Crude Heparin Sales Market Share by Type (2021-2032)
- 6.2 Global Crude Heparin Revenue by Type (2021-2032)
- 6.2.1 Global Crude Heparin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Crude Heparin Revenue Market Share by Type (2021-2032)
- 6.3 Global Crude Heparin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Crude Heparin Sales by Application (2021-2032)
- 7.1.1 Global Crude Heparin Sales by Application (2021-2032) & (t)
- 7.1.2 Global Crude Heparin Sales Market Share by Application (2021-2032)
- 7.2 Global Crude Heparin Revenue by Application (2021-2032)
- 7.2.1 Global Crude Heparin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Crude Heparin Revenue Market Share by Application (2021-2032)
- 7.3 Global Crude Heparin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Crude Heparin Value Chain Analysis
- 8.1.1 Crude Heparin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Crude Heparin Production Mode & Process
- 8.2 Crude Heparin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Crude Heparin Distributors
- 8.2.3 Crude Heparin Customers
9 Global Crude Heparin Analyzing Market Dynamics
- 9.1 Crude Heparin Industry Trends
- 9.2 Crude Heparin Industry Drivers
- 9.3 Crude Heparin Industry Opportunities and Challenges
- 9.4 Crude Heparin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst